The European Commission defines the bioeconomy as “The production of renewable biological resources and the conversion of these resources and waste streams into value-added products, such as food, feed, bio-based products and bioenergy. To be successful, the European bioeconomy needs to have sustainability and circularity at its heart. This will drive the renewal of industries, the modernisation of primary production systems, the protection of the environment and enhance biodiversity” (Source: European Bioeconomy Strategy).
There are therefore 3 important areas of the bioeconomy:
- agriculture, forestry, fishing and aquaculture;
- food, beverages and tobacco;
- other industries that use and/or transform biological resources (such as the paper, wood, cosmetics, pharmaceutical, chemicals, biotech, energy, textile and apparel industries).
The objective of the bioeconomy is to create a prosperous economy that respects the environment through the use of biological resources and renewable energy sources, with an ever-decreasing reliance on fossil fuels.
Opportunities in the sector:
- Development of Agriculture 4.0
- Smart territorial specialisation;
- Alternative energy sources;
- Growing bio-pharma demand;
- European Circular Bioeconomy Fund;
- Rising foreign demand.
Download the last report on the Italian biotech industry, drafted thanks to the consolidated collaboration between Assobiotec (Italian Association for the Development of Biotechnology, part of Federchimica) and ENEA (National Agency for New Technologies, Energy and Sustainable Economic Development), has been published in July 2021. The analysis offers an update on the current Italian biotech industry in 2020.
- In 2018, total national turnover from the bioeconomy reached €344.8 billion, up 2.2% on the previous year, which in turn recorded a 4.4% increase in 2016.
Foreign direct investment (FDI) in the agriculture, forestry and fishing segment came to €1.525 billion in 2018.
In February 2020, there were 941 start-ups and SME, of which 238 in Lombardy, 101 in Veneto and 87 in Campani
- Italy ranks 3rd in Europe in terms of turnover, behind only Germany and France.
Since 2008, BioInItaly Investment Forum is the key investment forum for biotechnology and life sciences innovation in Italy.
The event aims to bring together innovative businesses and projects seeking capital with financial and corporate investors from all over the world. Over the course of two days, startups selected by a panel of coaches and experts will present their projects to investors, corporations and players of the innovation ecosystem.
Join us for the live streaming on 12 April 2022 at 10.00 CEST for the Arena Investment Meeting where 6 start-ups will pitch to international investors.
- Live streaming 11 April (working language Italian only) - LINK
- Live streaming 12 April (working language English) -LINK
@ email us to discover the start-ups' teasers